IND Submission for CR-001, a PD-1 x VEGF Bispecific Antibody, on Track for Fourth Quarter of 2025 to Support Initiation of ...

Known for using unconventional materials — from Pearl Harbor seawater to meteorite moondust — in the name of horological ...

WALTHAM, Mass. (AP) — WALTHAM, Mass. (AP) — Spyre Therapeutics, Inc. (SYRE) on Tuesday reported a loss of $11.2 million in its third quarter. On a per-share basis, the Waltham, Massachusetts-based ...

Kailera Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on advancing a differentiated, late-stage portfolio of next-generation therapies for the treatment of obesity, today ...

The stock options are subject to the terms and conditions of Xilio Therapeutics' 2022 Inducement Stock Incentive Plan, as well as the terms and conditions of the stock option agreement covering the ...

In fact, the Waltham Watch Company singlehandedly manufactured more than 35 million watches and related items between 1854 ...